Dr.Reddys Laboratories reported 6.39B in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 4.8B 902M
Bharat Petroleum BPCL:IN 43.51B 5.55B
Cipla CIPLA:IN 8.89B 4.3B
Dr.Reddys Laboratories DRRD:IN 6.39B 2.6B
Reliance Infra RELI:IN 290.51B 56.86B
Sun Pharmaceuticals SUNP:IN 21.51B 5.28B
UPL UPLL:IN 17.55B 11.95B